4//SEC Filing
TREACE JOHN R 4
Accession 0001567619-22-010101
CIK 0001630627other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 5:59 PM ET
Size
12.7 KB
Accession
0001567619-22-010101
Insider Transaction Report
Form 4
TREACE JOHN R
Director
Transactions
- Sale
Common Stock
2022-05-09$13.30/sh−37,312$496,190→ 1,860,478 total(indirect: John R. Treace and Ginger D. Treace JTTEN) - Sale
Common Stock
2022-05-09$15.22/sh−18,415$280,197→ 1,823,097 total(indirect: John R. Treace and Ginger D. Treace JTTEN) - Sale
Common Stock
2022-05-09$14.20/sh−18,966$269,387→ 1,841,512 total(indirect: John R. Treace and Ginger D. Treace JTTEN) - Sale
Common Stock
2022-05-09$15.97/sh−307$4,902→ 1,822,790 total(indirect: John R. Treace and Ginger D. Treace JTTEN)
Holdings
- 408,816(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.93 to $13.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.93 to $14.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.93 to $15.891 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.96 to $15.97 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The Reporting Person disclaims beneficial ownership of shares held in trusts for which his spouse is a co-trustee.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001185249
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 5:59 PM ET
- Size
- 12.7 KB